MetfOrmin BenefIts Lower Extremities With Intermittent Claudication

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 200 participants.

Also called NCT05132439

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05132439
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05132439. Randomized; quadruple masking; primary purpose treatment. Start 2022-03-01 (actual); primary completion 2027-02-28 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
MetfOrmin BenefIts Lower Extremities With Intermittent Claudication
Acronym
MOBILE IC
Intervention (Drug)
Metformin ER
Intervention (Drug)
placebo
Lead sponsor
VA Office of Research and Development (class: US federal agency)
Collaborator
University of Pittsburgh (class: other)
Collaborator
Northwestern University (class: other)
Collaborator
San Francisco Veterans Affairs Medical Center (class: US federal agency)

Record details

Record id
cardio:ct-nct05132439
Content hash
eabbe38775b79fe5035e7776c67f6e702ab654032dc0b6277019fb91b542d047